Telo Genomics Corp Total Liabilities
Telo Genomics Corp total liabilities. Based on the latest financial reports, Telo Genomics Corp (TELO) has total liabilities worth CA$633.60K CAD (≈ $458.34K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See TELO defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Telo Genomics Corp (2012–2025)
Total liabilities of Telo Genomics Corp from 2012 to 2025. This chart illustrates how Telo Genomics Corp's total liabilities have evolved over time, based on quarterly financial data.
Telo Genomics Corp Competitors by Total Liabilities
The table below lists competitors of Telo Genomics Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Pure Foods Tasmania Ltd
AU:PFT
|
Australia | AU$8.26 Million |
|
Mesa Royalty Trust
NYSE:MTR
|
USA | $180.62K |
|
City Office
NYSE:CIO
|
USA | $456.78 Million |
|
Lupatech S.A
SA:LUPA3
|
Brazil | R$503.69 Million |
|
T3 Defense Inc.
NASDAQ:DFNS
|
USA | $159.77 Million |
|
Aberdeen New India Investment Trust PLC
LSE:ANII
|
UK | GBX21.67 Million |
|
Immunovia publ AB
ST:IMMNOV
|
Sweden | Skr24.40 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down Telo Genomics Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Telo Genomics Corp's balance sheet.
Liquidity & Leverage Metrics
Telo Genomics Corp Total Liabilities Ratios Explained
Telo Genomics Corp total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.93 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -23.73 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Telo Genomics Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Telo Genomics Corp (2012–2025)
The table below shows the annual total liabilities of Telo Genomics Corp from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | CA$396.32K ≈ $286.69K |
+5.52% |
| 2024-06-30 | CA$375.59K ≈ $271.69K |
+20.05% |
| 2023-06-30 | CA$312.87K ≈ $226.32K |
+35.99% |
| 2022-06-30 | CA$230.07K ≈ $166.43K |
+49.73% |
| 2021-06-30 | CA$153.66K ≈ $111.15K |
-60.94% |
| 2020-06-30 | CA$393.42K ≈ $284.59K |
-69.91% |
| 2019-06-30 | CA$1.31 Million ≈ $945.84K |
+75.85% |
| 2018-06-30 | CA$743.53K ≈ $537.86K |
-16.10% |
| 2017-06-30 | CA$886.25K ≈ $641.10K |
+2441.66% |
| 2016-06-30 | CA$34.87K ≈ $25.22K |
+113.93% |
| 2015-06-30 | CA$16.30K ≈ $11.79K |
-2.16% |
| 2014-06-30 | CA$16.66K ≈ $12.05K |
+22.43% |
| 2013-06-30 | CA$13.61K ≈ $9.84K |
-20.76% |
| 2012-06-30 | CA$17.17K ≈ $12.42K |
-- |
About Telo Genomics Corp
Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company's TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive o… Read more